Cargando…

Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors

The strength of goal-oriented behaviors is regulated by midbrain dopamine neurons. Dysfunctions of dopaminergic circuits are observed in drug addiction and obsessive-compulsive disorder. Compulsive behavior is a feature that both disorders share, which is associated to a heightened dopamine neurotra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Escobar, Angélica del Pilar, Casanova, José Patricio, Andrés, María Estela, Fuentealba, José Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040183/ https://www.ncbi.nlm.nih.gov/pubmed/32132923 http://dx.doi.org/10.3389/fphar.2020.00057

Ejemplares similares

Immunolocalization of kappa opioid receptors in the axon initial segment of a group of embryonic mesencephalic dopamine neurons
por: Escobar, Angélica Pilar, et al.
Publicado: (2022)

Mechanisms of Kappa Opioid Receptor Potentiation of Dopamine D2 Receptor Function in Quinpirole-Induced Locomotor Sensitization in Rats
por: Escobar, Angélica P, et al.
Publicado: (2017)

Does the kappa opioid receptor system contribute to pain aversion?
por: Cahill, Catherine M., et al.
Publicado: (2014)

It’s MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system
por: Chartoff, Elena H., et al.
Publicado: (2014)

The Neuronal Glutamate Transporter EAAT3 in Obsessive-Compulsive Disorder
por: Escobar, Angélica P., et al.
Publicado: (2019)

Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands
por: Sturaro, Chiara, et al.
Publicado: (2022)

Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction
por: Chartoff, Elena H., et al.
Publicado: (2015)

Repeated Administration of Norbinaltorphimine Produces Cumulative Kappa Opioid Receptor Inactivation
por: Chavkin, Charles, et al.
Publicado: (2019)

The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies
por: Dalefield, Martin L., et al.
Publicado: (2022)

Sex Differences in the Effects of a Kappa Opioid Receptor Antagonist in the Forced Swim Test
por: Laman-Maharg, Abigail, et al.
Publicado: (2018)

Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System
por: Leconte, Claire, et al.
Publicado: (2022)

Editorial: Kappa opioid receptors revealed: Disentangling the pharmacology to open up new therapeutic strategies
por: Walwyn, Wendy Margaret, et al.
Publicado: (2022)

Kappa Opioid Receptor Antagonism Rescues Genetic Perturbation of Dopamine Homeostasis: Molecular, Physiological and Behavioral Consequences
por: Mayer, Felix P, et al.
Publicado: (2023)

Kappa Opioid Receptor Blockade in the Amygdala Mitigates Pain Like-Behaviors by Inhibiting Corticotropin Releasing Factor Neurons in a Rat Model of Functional Pain
por: Yakhnitsa, Vadim, et al.
Publicado: (2022)

Exposure to chronic mild stress prevents kappa opioid-mediated reinstatement of cocaine and nicotine place preference
por: Al-Hasani, Ream, et al.
Publicado: (2013)

Sex Differences in Kappa Opioid Receptor Agonist Mediated Attenuation of Chemotherapy-Induced Neuropathic Pain in Mice
por: Paton, Kelly F., et al.
Publicado: (2022)

Agonist-Promoted Phosphorylation and Internalization of the Kappa Opioid Receptor in Mouse Brains: Lack of Connection With Conditioned Place Aversion
por: Chen, Chongguang, et al.
Publicado: (2022)

Supersensitive Kappa Opioid Receptors Promotes Ethanol Withdrawal-Related Behaviors and Reduce Dopamine Signaling in the Nucleus Accumbens
por: Rose, Jamie H., et al.
Publicado: (2015)

Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
por: Butelman, Eduardo R., et al.
Publicado: (2015)

Antinociceptive and Antipruritic Effects of HSK21542, a Peripherally-Restricted Kappa Opioid Receptor Agonist, in Animal Models of Pain and Itch
por: Wang, Xin, et al.
Publicado: (2021)

Type 2β Corticotrophin Releasing Factor Receptor Forms a Heteromeric Complex With Dopamine D1 Receptor in Living Cells
por: Yarur, Hector E., et al.
Publicado: (2020)

Cocaine self-administration augments kappa opioid receptor system-mediated inhibition of dopamine activity in the mesolimbic dopamine system
por: Estave, Paige M., et al.
Publicado: (2023)

Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
por: Butelman, Eduardo R., et al.
Publicado: (2015)

Kappa-Opioid Receptor Signaling in the Striatum as a Potential Modulator of Dopamine Transmission in Cocaine Dependence
por: Trifilieff, Pierre, et al.
Publicado: (2013)

Orexin 1 receptor antagonists in compulsive behavior and anxiety: possible therapeutic use
por: Merlo Pich, Emilio, et al.
Publicado: (2014)

In vitro and in vivo Pharmacological Activities of 14-O-Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in Mice
por: Lattanzi, Roberta, et al.
Publicado: (2018)

Behavioral Pharmacology of Novel Kappa Opioid Receptor Antagonists in Rats
por: Page, Sarah, et al.
Publicado: (2019)

Signaling underlying kappa opioid receptor-mediated behaviors in rodents
por: Liu-Chen, Lee-Yuan, et al.
Publicado: (2022)

Crosstalk between G protein-coupled receptors (GPCRs) and tyrosine kinase receptor (TXR) in the heart after morphine withdrawal
por: Almela, Pilar, et al.
Publicado: (2013)

Rapid-Onset Anti-Stress Effects of a Kappa-Opioid Receptor Antagonist, LY2795050, Against Immobility in an Open Space Swim Paradigm in Male and Female Mice
por: Baynard, Caroline, et al.
Publicado: (2021)

Identification of Critical Residues in the Carboxy Terminus of the Dopamine Transporter Involved in the G Protein βγ-Induced Dopamine Efflux
por: Pino, José A., et al.
Publicado: (2021)

Pharmacological profiles of opioid ligands at Kappa opioid receptors
por: Gharagozlou, Parham, et al.
Publicado: (2006)

Differential effects of novel kappa opioid receptor antagonists on dopamine neurons using acute brain slice electrophysiology
por: Margolis, Elyssa B., et al.
Publicado: (2020)

The crosstalk between sonodynamic therapy and autophagy in cancer
por: Zhang, Yujie, et al.
Publicado: (2022)

Classifying migraine using PET compressive big data analytics of brain’s μ-opioid and D2/D3 dopamine neurotransmission
por: Marino, Simeone, et al.
Publicado: (2023)

Therapeutic Potential of Kappa Opioid Agonists
por: Beck, Tyler C., et al.
Publicado: (2019)

Antiseizure medication in early nervous system development. Ion channels and synaptic proteins as principal targets
por: Castro, Patricio A., et al.
Publicado: (2022)

Crosstalk Between Dysfunctional Mitochondria and Inflammation in Glaucomatous Neurodegeneration
por: Jassim, Assraa Hassan, et al.
Publicado: (2021)

Adolescent Intermittent Ethanol Exposure Effects on Kappa Opioid Receptor Mediated Dopamine Transmission: Sex and Age of Exposure Matter
por: Spodnick, Mary B., et al.
Publicado: (2020)

Effects of mu- and kappa-2 opioid receptor agonists on pain and rearing behaviors
por: Neubert, John K, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_t4r0rm79hhj4fdhcqb4ag23t84